1 asset in Von Willebrand Disease 3

Therapeutic assets addressing Von Willebrand Disease 3, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Emicizumab Von Willebrand Disease 3	Bleeding and Clotting Disorders Institute Peoria, Illinois	P1	CC (43)